Access to this page has been denied because we believe you are using automation tools to browse the website. This may happen as a result of the following: Javascript is disabled or blocked by an extension (ad blockers for example) Your browser does not support cookies Please make sure that …

The two governments said they will coordinate more on defense, with British and German troops conducting joint military exercises on NATO’s eastern border. Source link

As November 5 draws closer, the Microsoft Threat Analysis Center (MTAC) warned on Wednesday that malicious foreign influence operations launched by Russia, China, and Iran against the US presidential election are continuing to evolve and should not be ignored even though they have come to feel inevitable. In the group’s …

Opaque communication. Lengthy deliberation. A bewildering outcome. Tennis, welcome to VAR: the source of existential angst, frustration, and rage across the English Premier League. This may sound hyperbolic, but since the introduction of Video Assistant Referees (VAR) to the top flight of English football five years ago, there has been …

Halloween brings spooky, scary, creepy and crawly movies to mind, but what about a despicable flick? Peacock picked a villain-friendly streaming date for Despicable Me 4, the latest film in the franchise that stars Gru and the Minions. In the sequel, Gru faces the revenge-seeking Maxime Le Mal and goes …

Shifts in behavior can be challenging to manage. Experts have five strategies that can help. Source link

In Yael van der Wouden’s debut novel, “The Safekeep,” the writer spins an erotic thriller out of the Netherlands’ failure to face up to the horrors of the Holocaust. Source link

Boeing (BA) released third quarter earnings on Wednesday morning, highlighting the precarious nature of the plane maker ahead of another momentous event: a labor vote set for later Wednesday. Boeing reported a net loss of $6.17 billion, bringing total losses in 2024 so far to nearly $8 billion. It said …

The economic lifeline is expected to be disbursed by the end of the year. Source link

Drugmaker Novo Nordisk is taking action to curb the massively popular compounded semaglutide industry, which provides copies of its blockbuster weight-loss drugs Ozempic and Wegovy to patients—often for much lower prices. The Danish pharmaceutical company is lobbying the US Food and Drug Administration to add semaglutide to the agency’s Demonstrable …